https://www.psychiatrictimes.com/view/the-first-and-only-5ht1a-receptor-agonist-for-major-depressive-disorder
0
0
11/1/23 at 4:01pm
Organization
Psychiatric Times
Gepirone, the first and only oral selective 5HT1a receptor agonist for the treatment of major depressive disorder in adults, is expected to arrive in early 2024.
Create an account
or login to join the discussion